COVID-19 vaccination was significantly associated with reduced risk of developing persistent long COVID, particularly when at least 2 doses were administered.

Having a previous SARS-CoV-2 infection provided a gradient of protection against reinfection, especially against severe forms of COVID-19.

The rate of AEs among pediatric patients with presumed TB disease was increased for those who received higher vs lower doses of WHO-recommended first-line treatment.

The top US health agency will no longer recommend the COVID-19 vaccine for healthy children and pregnant women.

In a guideline issued by the American College of Physicians, recommendations are presented for the use of statins among persons with HIV.

Updated CDC guidelines on PEP after nonoccupational HIV exposure address newer ART agents and clinical considerations for patients with a history of long-acting ART.

Following discharge for COVID-19 hospitalization, county-level social deprivation does not affect long-term cardiovascular risk.

Contact precautions were critical a component of MDRO prevention strategies, but the most effective interventions differed across health care settings and by resistant strain.

The US government has canceled a $600 million contract with Moderna to develop a vaccine for bird flu and other dangerous flu strains.

Moderna has withdrawn the BLA for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after consulting with FDA.

NIH staff walked out of a town hall meeting after Bhattacharya suggested the agency helped fund research that caused the COVID-19 pandemic.

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.